4.7 Article

Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Yojiro Hashiguchi et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Pathology

LEPR hypomethylation is significantly associated with gastric cancer in males

Hang Yu et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)

Article Oncology

Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns

Takehito Yamamoto et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)

Review Oncology

Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology

Al B. Benson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

Review Oncology

Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?

Sabrina Rossi et al.

CLINICAL COLORECTAL CANCER (2017)

Review Oncology

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

Arnoud J. Templeton et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Review Oncology

Cancer-related inflammation and treatment effectiveness

Connie I. Diakos et al.

LANCET ONCOLOGY (2014)

Review Oncology

The immune contexture in human tumours: impact on clinical outcome

Wolf Herman Fridman et al.

NATURE REVIEWS CANCER (2012)

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

Review Multidisciplinary Sciences

Cancer-related inflammation

Alberto Mantovani et al.

NATURE (2008)